Curofy Pharmaceuticals Private Limited
About Curofy Pharmaceuticals Private Limited
Data last updated:
Curofy Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2018PTC118491. Its GSTIN is 20AAHCC8598D1ZM (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Amandeep Singh and Bikky Kumari Rai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #29/2 & 29/3 F Block F No 301 Bangalore Karnataka – 560037, Karnataka, India – 560037.
As per the financials filed for FY 2025, the company reported a revenue of ₹81.82 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹3.02 Lakh (net margin 3.7%) and EBITDA of ₹8.75 Lakh (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹34 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Company details
Contact details
Curofy Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#29/2 & 29/3 F Block F No 301 Bangalore Karnataka – 560037, Karnataka, India – 560037
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Curofy Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curofy Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Curofy Pharmaceuticals Private Limited, buy the company report.
Financials of Curofy Pharmaceuticals Private Limited
FY 2025 filings availableCurofy Pharmaceuticals Private Limited reported revenue of ₹81.82 Lakh (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 447% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.7% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curofy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Curofy Pharmaceuticals Private Limited
Curofy Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amandeep Singh Also directs: Shubh Laxmi Hospitality Private Limited, Organic Hospitality LLP | Director | 18 Mar 2020 | 6 Years 7 Months | Current |
| Bikky Kumari Rai | Director | 13 Nov 2018 | 7 Years 11 Months | Current |
| Roshan Kumar | Director | 18 Mar 2021 | 5 Years 7 Months | Current |
Auditor
Curofy Pharmaceuticals Private Limited is audited by S A G A & ASSOCIATES LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S A G A & ASSOCIATES LLP | FY 2021 | N500034 |
Shareholding
The shareholding of Curofy Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Curofy Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Aug 2025 | 101144578 | Indian Overseas Bank | ₹10 Lakh | Open | |
| 18 Feb 2022 | 100566084 | Axis Bank Limited | ₹24 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Curofy Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, JHARKHAND | Writ petition | Filed against the company by Genomix Pharmaceuticals Private Limited Through Its Director Mr Mrinal Kumar Gupta and 1 other | Pending |
| High Court, JHARKHAND | Writ petition | Filed against the company by individuals | Pending |
To see the full case history of Curofy Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curofy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Curofy Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAHCC8598D1ZM | Jharkhand | Active | 29 Mar 2019 |
To see the full GST registrations and return filing status of Curofy Pharmaceuticals Private Limited, buy the company report.
Recent activity
Curofy Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Roshan Kumar was appointed as Director on 18 Mar 2021.
Frequently asked questions
Curofy Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 November 2018 (8+ years old) and is registered under CIN U51909KA2018PTC118491.
Curofy Pharmaceuticals has 3 current directors:
- Amandeep Singh - Director
- Bikky Kumari Rai - Director
- Roshan Kumar - Director
The latest financial statements of Curofy Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Curofy Pharmaceuticals is 20AAHCC8598D1ZM, registered in Jharkhand.
The CIN (Corporate Identification Number) of Curofy Pharmaceuticals is U51909KA2018PTC118491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curofy Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Curofy Pharmaceuticals was incorporated on 13 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Roshan Kumar was appointed as Director on 18 Mar 2021. Manish Kumar ceased to be Director on 28 Nov 2020. Rishi Ranjan ceased to be Director on 28 Nov 2020. Curofy Pharmaceuticals has 5 board changes on record in total.
The registered office of Curofy Pharmaceuticals is at #292 & 293 F Block F No 301 Bangalore Karnataka – 560037, Karnataka, India – 560037.
Curofy Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.